Evidence map›Paper›PMID 34322971›Full record

SynthesisInternational journal of clinical practice2021

The role of vitamin D in the age of COVID-19: A systematic review and meta-analysis.

Roya Ghasemian, Amir Shamshirian, Keyvan Heydari, Mohammad Malekan, Reza Alizadeh-Navaei, Mohammad Ali Ebrahimzadeh, Majid Ebrahimi Warkiani, Hamed Jafarpour, Sajad Razavi Bazaz, Arash Rezaei Shahmirzadi and 15 more

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in International journal of clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 8 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 8 syntheses or guidelines pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Vitamin D Deficiency and Comorbidities as Risk Factors of COVID-19 Infection: A Systematic Review and Meta-analysis.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2022
    Pooled it
  6. Effect of the COVID-19 Pandemic on Serum Vitamin D Levels in People Under Age 18 Years: A Systematic Review and Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2022
    Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Expression ofFuture virology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 3 countries.

Roya GhasemianAntimicrobial Resistance Research Center, Department of Infectious Diseases, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0001-7330-7749
Amir ShamshirianDepartment of Medical Laboratory Sciences, Student Research Committee, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-2735-0209
Keyvan HeydariGastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-2843-7832
Mohammad MalekanStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-5622-0294
Reza Alizadeh-NavaeiGastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0003-0580-000X
Mohammad Ali EbrahimzadehPharmaceutical Sciences Research Center, Department of Medicinal Chemistry, School of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.ORCID https://orcid.org/0000-0002-8769-9912
Majid Ebrahimi WarkianiSchool of Biomedical Engineering, University of Technology Sydney, Sydney, Ultimo, NSW, Australia.ORCID https://orcid.org/0000-0002-4184-1944
Hamed JafarpourStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0003-0652-2363
Sajad Razavi BazazSchool of Biomedical Engineering, University of Technology Sydney, Sydney, Ultimo, NSW, Australia.ORCID https://orcid.org/0000-0002-6419-3361
Arash Rezaei ShahmirzadiStudent Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.
Mehrdad KhodabandehNeuromusculoskeletal Research Center, Department of Physical Medicine and Rehabilitation, Iran University of Medical Sciences, Tehran, Iran.
Benyamin SeyfariDepartment of Surgery, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Alireza MotamedzadehDepartment of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Ehsan DadgostarDepartment of Psychiatry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-4041-7324
Marzieh AalinezhadDepartment of Radiology, Isfahan University of Medical Sciences, Isfahan, Iran.ORCID https://orcid.org/0000-0002-3365-2844
Meghdad SedaghatDepartment of Internal Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-3966-0597
Nazanin RazzaghiStudent Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.
Bahman ZarandiStudent Research Committee, Iran University of Medical Sciences, Tehran, Iran.
Anahita AsadiPharmaceutical Sciences Research Center, Department of Medicinal Chemistry, School of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.
Vahid Yaghoubi NaeiImmunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Reza BeheshtiPharmaceutical Sciences Research Center, Department of Medicinal Chemistry, School of Pharmacy, Mazandaran University of Medical Science, Sari, Iran.
Amirhossein HessamiDepartment of Medical Laboratory Sciences, Student Research Committee, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-1219-1081
Soheil AziziDepartment of Medical Laboratory Sciences, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0002-8802-4255
Ali Reza MohseniDepartment of Medical Laboratory Sciences, School of Allied Medical Science, Mazandaran University of Medical Sciences, Sari, Iran.ORCID https://orcid.org/0000-0001-9347-5096
Danial ShamshirianChronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0001-8461-3477
Mazandaran University of Medical Sciences · IRGolestan University · IRIran University of Medical Sciences · IRIsfahan University of Medical Sciences · IRKashan University of Medical Sciences · IRUniversity of Technology Sydney · AUImam Hossein Hospital · IRMashhad University of Medical Sciences · IRMasih Daneshvari Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEvidence recommends that vitamin D might be a crucial supportive agent for the immune system, mainly in cytokine response regulation against COVID-19. Hence, we carried out a systematic review and meta-analysis in order to maximise the use of everything that exists about the role of vitamin D in the COVID-19.

methodsA systematic search was performed in PubMed, Scopus, Embase and Web of Science up to December 18, 2020. Studies focused on the role of vitamin D in confirmed COVID-19 patients were entered into the systematic review.

resultsTwenty-three studies containing 11 901 participants entered into the meta-analysis. The meta-analysis indicated that 41% of COVID-19 patients were suffering from vitamin D deficiency (95% CI, 29%-55%), and in 42% of patients, levels of vitamin D were insufficient (95% CI, 24%-63%). The serum 25-hydroxyvitamin D concentration was 20.3 ng/mL among all COVID-19 patients (95% CI, 12.1-19.8). The odds of getting infected with SARS-CoV-2 are 3.3 times higher among individuals with vitamin D deficiency (95% CI, 2.5-4.3). The chance of developing severe COVID-19 is about five times higher in patients with vitamin D deficiency (OR: 5.1, 95% CI, 2.6-10.3). There is no significant association between vitamin D status and higher mortality rates (OR: 1.6, 95% CI, 0.5-4.4).

conclusionThis study found that most of the COVID-19 patients were suffering from vitamin D deficiency/insufficiency. Also, there is about three times higher chance of getting infected with SARS-CoV-2 among vitamin-D-deficient individuals and about five times higher probability of developing the severe disease in vitamin-D-deficient patients. Vitamin D deficiency showed no significant association with mortality rates in this population.

Indexed as

COVID-19Vitamin D DeficiencyHumansSARS-CoV-2Vitamin DVitaminsVitamin DVitamins

Identifiers

PMID34322971
PMCPMC8420549
OpenAlexW3183515822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.